Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis c Genotype 1”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00680173
What this trial is testing

Peripheral Blood Mononuclear Cell (PBMC) Gene Expression in HCV Genotype 1 Patients

Who this might be right for
Chronic Hepatitis C
Kaohsiung Medical University Chung-Ho Memorial Hospital 30
Early research (Phase 1)Study completedNCT01818856
What this trial is testing

Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir

Who this might be right for
Hepatitis C, ChronicHIV Infection
Hospitales Universitarios Virgen del Rocío 14
Not applicableStudy completedNCT03002818
What this trial is testing

Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)

Who this might be right for
Chronic Hepatitis C Virus (HCV)
AbbVie 41
Large-scale testing (Phase 3)Study completedNCT01579474
What this trial is testing

Japanese Pegylated Interferon (PegIFN) Alfa-2b/Ribavirin (RBV) Combination Trial

Who this might be right for
Hepatitis C
Boehringer Ingelheim 131
Post-approval studies (Phase 4)Study completedNCT00192647
What this trial is testing

Induction Dosing With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C (CHC) Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 896
Testing effectiveness (Phase 2)Study completedNCT02226549
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination and Vedroprevir With or Without Ribavirin in Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection and Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 47
Large-scale testing (Phase 3)WithdrawnNCT01590225
What this trial is testing

Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT01753557
What this trial is testing

Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C

Who this might be right for
Chronic Hepatitis C (CHC)
Tanabe Pharma Corporation 54
Large-scale testing (Phase 3)Ended earlyNCT00423800
What this trial is testing

Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)(TERMINATED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 56
Large-scale testing (Phase 3)Study completedNCT01366638
What this trial is testing

TMC435 in Participants With Genotype 1 Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 79
Large-scale testing (Phase 3)Study completedNCT01753570
What this trial is testing

Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC)

Who this might be right for
Chronic Hepatitis C(CHC)
Tanabe Pharma Corporation 74
Early research (Phase 1)Study completedNCT00230854
What this trial is testing

Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin

Who this might be right for
Chronic Hepatitis CHepatitis, Viral, Human
OPKO Health, Inc. 28
Not applicableStudy completedNCT00854802
What this trial is testing

Debio 025 (Alisporivir) Combined With Peg-IFNα2a and Ribavirin in Treatment naïve Chronic Hepatitis C Genotype 1 Patients

Who this might be right for
Chronic Hepatitis C
Debiopharm International SA 290
Large-scale testing (Phase 3)UnknownNCT00485342
What this trial is testing

RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of Ribavirin

Who this might be right for
Chronic Hepatitis C
Hospices Civils de Lyon 236
Testing effectiveness (Phase 2)WithdrawnNCT02556086
What this trial is testing

A Phase 2b Evaluation of Daclatasvir/Sofosbuvir in Non-Cirrhotic Treatment Naive Subjects With Genotype 1, 2, 3 and 4 Chronic Hepatitis C Virus Coinfected With Human Immunodeficiency Virus (HIV-1)

Who this might be right for
Hepatitis C
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT01466790
What this trial is testing

TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Patients

Who this might be right for
Hepatitis C
Janssen R&D Ireland 168
Testing effectiveness (Phase 2)Study completedNCT01458535
What this trial is testing

Evaluate Paritaprevir With Ritonavir (ABT-450/r) When Given Together With Ombitasvir and With and Without Ribavirin (RBV) in Treatment-Naïve Participants With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C Virus
AbbVie (prior sponsor, Abbott) 61
Testing effectiveness (Phase 2)Study completedNCT01482390
What this trial is testing

Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Hoffmann-La Roche 80
Not applicableStudy completedNCT01980290
What this trial is testing

Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis, Chronic
Janssen Pharmaceutica N.V., Belgium 50
Early research (Phase 1)Study completedNCT01247194
What this trial is testing

A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1

Who this might be right for
Chronic Genotype 1 Hepatitis C Virus Infection
Presidio Pharmaceuticals, Inc. 24
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation